Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Amgen Inc Transaction History

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H

$3.1 Billion
Q3 2024

A detailed history of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H transactions in Amgen Inc stock. As of the latest transaction made, Meag Munich Ergo, Kapitalanlagegesellschaft Mb H holds 726 shares of AMGN stock, worth $213,828. This represents 0.01% of its overall portfolio holdings.

Number of Shares

726

Holding current value

$213,828

% of portfolio

0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$309.38 - $337.38 $224,609 - $244,937	726 New	726 $233,000
Q4 2023 Jan 19, 2024	SELL	$255.7 - $288.46 $4.68 Million - $5.28 Million	-18,300 Reduced 96.25%	713 $205,000
Q3 2023 Oct 25, 2023	BUY	$218.65 - $271.46 $2.03 Million - $2.51 Million	9,264 Added 95.03%	19,013 $5.11 Million
Q2 2023 Jul 14, 2023	SELL	$214.27 - $253.37 $89,993 - $106,415	-420 Reduced 4.13%	9,749 $2.16 Million
Q1 2023 Apr 20, 2023	SELL	$225.79 - $275.2 $2.97 Million - $3.63 Million	-13,175 Reduced 56.44%	10,169 $2.46 Million
Q4 2022 Jan 19, 2023	SELL	$229.03 - $291.01 $512,111 - $650,698	-2,236 Reduced 8.74%	23,344 $6.13 Million
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $4.24 Million - $4.78 Million	18,874 Added 281.45%	25,580 $5.77 Million
Q2 2022 Jul 19, 2022	BUY	$230.71 - $256.74 $159,882 - $177,920	693 Added 11.53%	6,706 $1.63 Million
Q1 2022 Apr 13, 2022	BUY	$219.27 - $242.57 $989,565 - $1.09 Million	4,513 Added 300.87%	6,013 $1.47 Million
Q4 2021 Jan 25, 2022	SELL	$198.88 - $227.6 $3.17 Million - $3.63 Million	-15,946 Reduced 91.4%	1,500 $341,000
Q2 2021 Jul 16, 2021	SELL	$233.58 - $259.14 $5.79 Million - $6.42 Million	-24,770 Reduced 58.67%	17,446 $4.25 Million
Q1 2021 Apr 20, 2021	BUY	$221.91 - $258.6 $3.96 Million - $4.61 Million	17,834 Added 73.14%	42,216 $10.5 Million
Q3 2020 Oct 20, 2020	SELL	$234.65 - $260.95 $348,924 - $388,032	-1,487 Reduced 5.75%	24,382 $6.2 Million
Q2 2020 Jul 16, 2020	SELL	$197.81 - $242.74 $2.11 Million - $2.59 Million	-10,668 Reduced 29.2%	25,869 $6.1 Million
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $772,515 - $1.02 Million	-4,239 Reduced 10.4%	36,537 $7.41 Million
Q4 2019 Jan 17, 2020	SELL	$189.21 - $243.2 $3 Million - $3.86 Million	-15,878 Reduced 28.03%	40,776 $9.8 Million
Q3 2019 Oct 29, 2019	BUY	$174.11 - $208.62 $3.85 Million - $4.61 Million	22,113 Added 64.02%	56,654 $11 Million
Q2 2019 Jul 17, 2019	BUY	$166.7 - $195.41 $982,363 - $1.15 Million	5,893 Added 20.57%	34,541 $6.37 Million
Q1 2019 Apr 29, 2019	SELL	$180.87 - $203.88 $6,692 - $7,543	-37 Reduced 0.13%	28,648 $5.37 Million
Q4 2018 Jan 29, 2019	SELL	$178.4 - $208.25 $2.8 Million - $3.27 Million	-15,710 Reduced 35.39%	28,685 $5.48 Million
Q3 2018 Oct 23, 2018	BUY	$185.29 - $208.89 $3.78 Million - $4.26 Million	20,395 Added 84.98%	44,395 $9.22 Million
Q2 2018 Jul 17, 2018	SELL	$166.05 - $186.51 $10.4 Million - $11.7 Million	-62,730 Reduced 72.33%	24,000 $4.44 Million
Q1 2018 May 02, 2018	BUY	$169.43 - $198.0 $2.44 Million - $2.85 Million	14,419 Added 19.94%	86,730 $14.7 Million
Q4 2017 Jan 26, 2018	BUY	$168.79 - $188.59 $3.68 Million - $4.11 Million	21,798 Added 43.15%	72,311 $12.7 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $8.45 Million - $9.65 Million	50,513	50,513 $9.4 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.

Account

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Amgen Inc Transaction History